Medications

Q&A: Experts discuss pros, cons of new Alzheimer's drug

Patient care teams are preparing to offer lecanemab, a new Alzheimer's disease treatment expected to soon receive approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.

Oncology & Cancer

Blood test aids in predicting lung cancer mortality risk

A blood-based test developed by researchers at The University of Texas MD Anderson Cancer Center can efficiently predict an individual's risk of dying from lung cancer when combined with a personalized risk model.

Health

Study shines light on 'low-value' vitamin D tests

Doctors are ordering unnecessary, costly and invasive blood tests for children to detect vitamin D deficiency, when instead it would be better to take simple preventative steps to ensure children receive supplements of the ...

Cardiology

The lesser-known risk factors for heart disease

Most people know that the risk factors for heart disease are high blood pressure, smoking, raised cholesterol and being overweight. However, many people who have a heart attack do not have any of these traditional risk factors.

page 21 from 40